.After increasing $170 million back in February, metabolic disease-focused BioAge Labs has filed to ...
.Aelis Farma's chances of protecting a simple, beneficial selection on a $one hundred million choice...
.ProKidney has actually ceased some of a pair of phase 3 trials for its cell therapy for renal ailme...
.Vaxcyte revealed what analysts named "sensational" stage 1/2 data for its 31-valent pneumococcal in...
.Recursion has actually discovered with an early examination of its own tech-enabled approach to med...
.Contact it a situation of good chemistry: Acepodia, a biotech based upon Nobel Prize-winning scient...
.Practice Precision Medicines has racked up one more midphase succeed in epilepsy this year, with it...
.After getting away a scientific grip a number of years back, Dyne Therapy has uncovered new phase 1...
.Arrowhead Pharmaceuticals has actually presented its hand ahead of a possible face-off with Ionis, ...
.Pfizer as well as Valneva might possess regarding two more years to stand by prior to they make the...